Supplementary Table 3 from Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors

2026 Open access

Read full text
Authors: Kyle Brandon Williams, Alex T. Larsson, Bryant J. Keller, Katherine E. Chaney, Rory L. Williams, Minu M. Bhunia, Garrett M. Draper, Tyler A. Jubenville, Wendy A. Hudson, Gunda I. Georg, Christopher L. Moertel, Nancy Ratner
+1 more David A. Largaespada
DOI: 10.1158/1535-7163.31248644
Cited by: 0

Abstract

Supplementary Table 3 shows the combination index determination results of small molecules used in this study when combined with a MEK inhibitor.

Fields of Study & Subjects

Neurofibromatosis and Schwannoma Cases Melanoma and MAPK Pathways Protein Tyrosine Phosphatases

Publication details

Publication date
4 February 2026